Literature DB >> 9291827

Considerable plasma levels of a cytotoxic etoposide metabolite in patients undergoing high-dose chemotherapy.

S Stremetzne, U Jaehde, R Kasper, J Beyer, W Siegert, W Schunack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9291827     DOI： 10.1016/s0959-8049(97)00087-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells.

Authors:  Irina I Vlasova; Wei-Hong Feng; Julie P Goff; Angela Giorgianni; Duc Do; Susanne M Gollin; Dale W Lewis; Valerian E Kagan; Jack C Yalowich
Journal:  Mol Pharmacol       Date:  2010-11-19       Impact factor: 4.436

2.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

Authors:  B D Lovett; L Lo Nigro; E F Rappaport; I A Blair; N Osheroff; N Zheng; M D Megonigal; W R Williams; P C Nowell; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

3.  Etoposide quinone is a redox-dependent topoisomerase II poison.

Authors:  David A Jacob; Susan L Mercer; Neil Osheroff; Joseph E Deweese
Journal:  Biochemistry       Date:  2011-06-02       Impact factor: 3.162

Review 4.  Topoisomerase II and leukemia.

Authors:  Maryjean Pendleton; R Hunter Lindsey; Carolyn A Felix; David Grimwade; Neil Osheroff
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.